A daily pill could almost double the survival time of patients with pancreatic cancer.
A trial has also found daraxonrasib has fewer side-effects than chemotherapy.
Pancreatic cancer has the highest mortality rate of all major cancers.
Dr Katherine Free from Pancreatic Cancer UK says the drug could be a game-changer.
IN: 'It targets...
OUT: ...diagnosis.'
DUR: 30 seconds
http://www.fsnradionews.com/feeds/0601pancreatic-free1.mp3
A trial has also found daraxonrasib has fewer side-effects than chemotherapy.
Pancreatic cancer has the highest mortality rate of all major cancers.
Dr Katherine Free from Pancreatic Cancer UK says the drug could be a game-changer.
IN: 'It targets...
OUT: ...diagnosis.'
DUR: 30 seconds
http://www.fsnradionews.com/feeds/0601pancreatic-free1.mp3